A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.
Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...
MUMBAI: India's heart disease burden is evident not only from the spate of heart attacks among young celebrities in the past five years, but also in the over-50% rise in cardiac medication sale in the ...
When someone survives a heart attack, their recovery journey often includes a small pharmacy of medications—each serving a specific purpose in their healing process and long-term protection.
—An analysis of population-based data revealed that males born with DMD experienced prolonged survival when cardiac medication was initiated while LVF was normal, highlighting an area of focus for ...
Consensus directed medical therapy (CDMT) was used in 73.1% of DMD patients with moderate or severe left ventricular dysfunction, leaving nearly 30% without recommended treatment. Target doses were ...
The medication can reduce risk of cardiovascular disease and improve quality of life for those living with CVD. Nutrition and ...
The province announced $2.5 million on Thursday to equip advanced care paramedics with pre-hospital thrombolytics for cardiac ...